999 related articles for article (PubMed ID: 16244497)
1. Expression analysis of hypothalamic and pituitary components of the growth hormone axis in fasted and streptozotocin-treated neuropeptide Y (NPY)-intact (NPY+/+) and NPY-knockout (NPY-/-) mice.
Park S; Peng XD; Frohman LA; Kineman RD
Neuroendocrinology; 2005; 81(6):360-71. PubMed ID: 16244497
[TBL] [Abstract][Full Text] [Related]
2. Differential responses of the growth hormone axis in two rat models of streptozotocin-induced insulinopenic diabetes.
Kim E; Sohn S; Lee M; Jung J; Kineman RD; Park S
J Endocrinol; 2006 Feb; 188(2):263-70. PubMed ID: 16461552
[TBL] [Abstract][Full Text] [Related]
3. The growth hormone (GH)-axis of GH receptor/binding protein gene-disrupted and metallothionein-human GH-releasing hormone transgenic mice: hypothalamic neuropeptide and pituitary receptor expression in the absence and presence of GH feedback.
Peng XD; Park S; Gadelha MR; Coschigano KT; Kopchick JJ; Frohman LA; Kineman RD
Endocrinology; 2001 Mar; 142(3):1117-23. PubMed ID: 11181526
[TBL] [Abstract][Full Text] [Related]
4. Severity of the catabolic condition differentially modulates hypothalamic expression of growth hormone-releasing hormone in the fasted mouse: potential role of neuropeptide Y and corticotropin-releasing hormone.
Luque RM; Park S; Kineman RD
Endocrinology; 2007 Jan; 148(1):300-9. PubMed ID: 17038558
[TBL] [Abstract][Full Text] [Related]
5. Fasting-induced changes in the hypothalamic-pituitary-GH axis in the absence of GH expression: lessons from the spontaneous dwarf rat.
Park S; Sohn S; Kineman RD
J Endocrinol; 2004 Mar; 180(3):369-78. PubMed ID: 15012591
[TBL] [Abstract][Full Text] [Related]
6. Effects of leptin replacement on hypothalamic-pituitary growth hormone axis function and circulating ghrelin levels in ob/ob mice.
Luque RM; Huang ZH; Shah B; Mazzone T; Kineman RD
Am J Physiol Endocrinol Metab; 2007 Mar; 292(3):E891-9. PubMed ID: 17122091
[TBL] [Abstract][Full Text] [Related]
7. Growth hormone (GH)-releasing hormone (GHRH) and the GH secretagogue (GHS), L692,585, differentially modulate rat pituitary GHS receptor and GHRH receptor messenger ribonucleic acid levels.
Kineman RD; Kamegai J; Frohman LA
Endocrinology; 1999 Aug; 140(8):3581-6. PubMed ID: 10433214
[TBL] [Abstract][Full Text] [Related]
8. Hypothalamic/pituitary-axis of the spontaneous dwarf rat: autofeedback regulation of growth hormone (GH) includes suppression of GH releasing-hormone receptor messenger ribonucleic acid.
Kamegai J; Unterman TG; Frohman LA; Kineman RD
Endocrinology; 1998 Aug; 139(8):3554-60. PubMed ID: 9681507
[TBL] [Abstract][Full Text] [Related]
9. Examination of the direct effects of metabolic factors on somatotrope function in a non-human primate model, Papio anubis.
Luque RM; Gahete MD; Valentine RJ; Kineman RD
J Mol Endocrinol; 2006 Aug; 37(1):25-38. PubMed ID: 16901921
[TBL] [Abstract][Full Text] [Related]
10. Growth hormone-releasing hormone (GHRH) neurons in the arcuate nucleus (Arc) of the hypothalamus are decreased in transgenic rats whose expression of ghrelin receptor is attenuated: Evidence that ghrelin receptor is involved in the up-regulation of GHRH expression in the arc.
Mano-Otagiri A; Nemoto T; Sekino A; Yamauchi N; Shuto Y; Sugihara H; Oikawa S; Shibasaki T
Endocrinology; 2006 Sep; 147(9):4093-103. PubMed ID: 16728494
[TBL] [Abstract][Full Text] [Related]
11. Modulation of pituitary somatostatin receptor subtype (sst1-5) messenger ribonucleic acid levels by changes in the growth hormone axis.
Park S; Kamegai J; Johnson TA; Frohman LA; Kineman RD
Endocrinology; 2000 Oct; 141(10):3556-63. PubMed ID: 11014208
[TBL] [Abstract][Full Text] [Related]
12. Autofeedback suppression of growth hormone (GH) secretion in transgenic mice expressing a human GH reporter targeted by tyrosine hydroxylase 5'-flanking sequences to the hypothalamus.
Szabo M; Butz MR; Banerjee SA; Chikaraishi DM; Frohman LA
Endocrinology; 1995 Sep; 136(9):4044-8. PubMed ID: 7649113
[TBL] [Abstract][Full Text] [Related]
13. Plasma and hypothalamic peptide-hormone levels regulating somatotroph function and energy balance in fed and fasted states: a comparative study in four strains of rats.
Kappeler L; Zizzari P; Grouselle D; Epelbaum J; Bluet-Pajot MT
J Neuroendocrinol; 2004 Dec; 16(12):980-8. PubMed ID: 15667453
[TBL] [Abstract][Full Text] [Related]
14. Gene expression of hypothalamic growth hormone (GH)-releasing hormone and somatostatin does not correlate with pulsatile secretion of GH in the adult mouse.
Murao S; Sato M; Tamaki M; Niimi M; Ishida T; Takahara J
Res Commun Mol Pathol Pharmacol; 1995 Sep; 89(3):269-77. PubMed ID: 8680796
[TBL] [Abstract][Full Text] [Related]
15. Oestrogen replacement in vivo rescues the dysfunction of pituitary somatotropes in ovariectomised aromatase knockout mice.
Yan M; Jones ME; Hernandez M; Liu D; Simpson ER; Chen C
Neuroendocrinology; 2005; 81(3):158-66. PubMed ID: 16015026
[TBL] [Abstract][Full Text] [Related]
16. Growth hormone-releasing hormone receptor (GHRH-R) and growth hormone secretagogue receptor (GHS-R) mRNA levels during postnatal development in male and female rats.
Kamegai J; Wakabayashi I; Kineman RD; Frohman LA
J Neuroendocrinol; 1999 Apr; 11(4):299-306. PubMed ID: 10223284
[TBL] [Abstract][Full Text] [Related]
17. Homologous and heterologous regulation of pituitary receptors for ghrelin and growth hormone-releasing hormone.
Luque RM; Kineman RD; Park S; Peng XD; Gracia-Navarro F; Castaño JP; Malagon MM
Endocrinology; 2004 Jul; 145(7):3182-9. PubMed ID: 15044357
[TBL] [Abstract][Full Text] [Related]
18. Effects of a high-glucose environment on the pituitary growth hormone-releasing hormone receptor: type 1 diabetes compared with in vitro glucotoxicity.
Bédard K; Strecko J; Thériault K; Bédard J; Veyrat-Durebex C; Gaudreau P
Am J Physiol Endocrinol Metab; 2008 Apr; 294(4):E740-51. PubMed ID: 18285528
[TBL] [Abstract][Full Text] [Related]
19. Gender-dependent role of endogenous somatostatin in regulating growth hormone-axis function in mice.
Luque RM; Kineman RD
Endocrinology; 2007 Dec; 148(12):5998-6006. PubMed ID: 17761762
[TBL] [Abstract][Full Text] [Related]
20. Hexarelin modulates the expression of growth hormone secretagogue receptor type 1a mRNA at hypothalamic and pituitary sites.
Bresciani E; Nass R; Torsello A; Gaylinn B; Avallone R; Locatelli V; Thorner MO; Müller EE
Neuroendocrinology; 2004; 80(1):52-9. PubMed ID: 15361691
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
